Michail Sideris

ORCID: 0000-0002-4199-6700 · 6 papers in corpus
review 2025
Cancers ·doi:10.3390/cancers17030545

Borderline Ovarian Tumours (BOTs) are a heterogenous group of ovarian neoplasms which have increased mitotic activity but lack stromal invasion. We performed a narrative review of the literature, aiming to identify prognostic molecular biom…

case-report 2023
Annals of medicine and surgery (2012) ·doi:10.1097/ms9.0000000000000884

UNLABELLED: Benign metastasizing leiomyoma (BML) is a rare disorder characterized by the presence of benign smooth muscle tumours in extrauterine sites, typically the lungs. It classically involves perimenopausal women with a history of ute…

review 2022
Cancers ·doi:10.3390/cancers14235832

BACKGROUND: Risk-reducing hysterectomy (RRH) is the gold-standard prevention for endometrial cancer (EC). Knowledge of the impact on quality-of-life (QoL) is crucial for decision-making. This systematic review aims to summarise the evidence…

case-report 2021
Annals of medicine and surgery (2012) ·doi:10.1016/j.amsu.2020.12.020

INTRODUCTION: Spontaneous uterine rupture before onset of labour is extremely rare. This is even more so in the second trimester of pregnancy, in nulliparous women and in the absence of myometrial surgery. The initial presentation of this p…

observational 2020
In vivo (Athens, Greece) ·doi:10.21873/invivo.11826

BACKGROUND: Leiomyomas are common in women of reproductive age, for whom treatment-stratification can be challenging. We assessed factors influencing pre-operative selection of surgical intervention and compare outcomes. PATIENTS AND METHO…

review 2019
In vivo (Athens, Greece) ·doi:10.21873/invivo.11616

Power morcellation remains one of the most significant developments in minimal access surgery over the past decade, allowing many more patients to benefit from the least invasive surgical route. However, its use is not without controversy, …